Loader

Pathways

PathWhiz ID Pathway Meta Data

PW128458

Pw128458 View Pathway
drug action

Dapsone Action Pathway

Physalis cinerascens
Dapsone is an antibacterial from the sulfone drug class. It is indicated for the treatment of acne vulgaris, Hansen's disease, and dermatitis herpetiformis. Its main action is against Mycobacterium leprae. This drug acts against bacteria and protozoa by binding to the dihydropteroate synthetase enzyme. This is a competitive inhibition in the active site of para-amino-benzoate on the protein. It results in the inhibition of an essential reaction in the synthesis of dihydrofolic acid. The inability to produce folic acid results in the inhibition of the growth of the bacteria or protozoa. This drug is mostly administered as a topical gel. It is also available as an oral tablet.

PW144379

Pw144379 View Pathway
drug action

Dapsone Drug Metabolism Action Pathway

Homo sapiens

PW144259

Pw144259 View Pathway
drug action

Daptomycin Drug Metabolism Action Pathway

Homo sapiens

PW132518

Pw132518 View Pathway
metabolic

Daridorexant Drug Metabolism

Homo sapiens
Daridorexant is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis. Daridorexant passes through the liver and is then excreted from the body mainly through the kidney.

PW146904

Pw146904 View Pathway
drug action

Daridorexant Drug Metabolism Action Pathway

Homo sapiens

PW127974

Pw127974 View Pathway
drug action

Darifenacin Action Pathway

Homo sapiens
Darifenacin is an M3 muscarinic receptor blocker used to treat urinary incontinence. It can be found under the brand names Emselex and Enablex. Darifenacin blocks M3 muscarinic acetylcholine receptors, which mediate bladder muscle contractions. This block reduces the urgency to urinate and so it should not be used in people with urinary retention. Darifenacin is a competitive muscarinic receptor antagonist. In vitro studies using human recombinant muscarinic receptor subtypes show that darifenacin has greater affinity for the M3 receptor than for the other known muscarinic receptors (9 and 12-fold greater affinity for M3 compared to M1 and M5, respectively, and 59-fold greater affinity for M3 compared to both M2 and M4). Muscarinic receptors play an important role in several major cholinergically mediated functions, including contractions of the urinary bladder smooth muscle and stimulation of salivary secretion. Possible side effects of using derifenacin may include dry mouth, constipation, stomach pain, and weakness.

PW132591

Pw132591 View Pathway
metabolic

Darifenacin Drug Metabolism

Homo sapiens
Darifenacin is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis. Darifenacin passes through the liver and is then excreted from the body mainly through the kidney.

PW144618

Pw144618 View Pathway
drug action

Darifenacin Drug Metabolism Action Pathway

Homo sapiens

PW146569

Pw146569 View Pathway
drug action

Darolutamide Drug Metabolism Action Pathway

Homo sapiens

PW176014

Pw176014 View Pathway
metabolic

Darolutamide Predicted Metabolism Pathway new

Homo sapiens
Metabolites of Darolutamide are predicted with biotransformer.